BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28039460)

  • 1. Loss of FOXN3 in colon cancer activates beta-catenin/TCF signaling and promotes the growth and migration of cancer cells.
    Dai Y; Wang M; Wu H; Xiao M; Liu H; Zhang D
    Oncotarget; 2017 Feb; 8(6):9783-9793. PubMed ID: 28039460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of LRP1B in colon cancer promoted the growth and migration of cancer cells.
    Wang Z; Sun P; Gao C; Chen J; Li J; Chen Z; Xu M; Shao J; Zhang Y; Xie J
    Exp Cell Res; 2017 Aug; 357(1):1-8. PubMed ID: 28408316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXN3 suppresses the growth and invasion of papillary thyroid cancer through the inactivation of Wnt/β-catenin pathway.
    Zhao C; Mo L; Li C; Han S; Zhao W; Liu L
    Mol Cell Endocrinol; 2020 Sep; 515():110925. PubMed ID: 32619584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-574-5p Targets FOXN3 to Regulate the Invasion of Nasopharyngeal Carcinoma Cells via Wnt/β-Catenin Pathway.
    Lin Z; Chen M; Wan Y; Lei L; Ruan H
    Technol Cancer Res Treat; 2020; 19():1533033820971659. PubMed ID: 33317407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YEATS4 promotes the tumorigenesis of pancreatic cancer by activating beta-catenin/TCF signaling.
    Jixiang C; Shengchun D; Jianguo Q; Zhengfa M; Xin F; Xuqing W; Jianxin Z; Lei C
    Oncotarget; 2017 Apr; 8(15):25200-25210. PubMed ID: 28445953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.
    Stein U; Arlt F; Walther W; Smith J; Waldman T; Harris ED; Mertins SD; Heizmann CW; Allard D; Birchmeier W; Schlag PM; Shoemaker RH
    Gastroenterology; 2006 Nov; 131(5):1486-500. PubMed ID: 17101323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells.
    Wang Q; Sun Z; Yang HS
    Oncogene; 2008 Mar; 27(11):1527-35. PubMed ID: 17828298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer.
    Vignjevic D; Schoumacher M; Gavert N; Janssen KP; Jih G; Laé M; Louvard D; Ben-Ze'ev A; Robine S
    Cancer Res; 2007 Jul; 67(14):6844-53. PubMed ID: 17638895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOL8, the binding protein for beta-catenin, promoted the growth and migration of prostate cancer cells.
    Gu S; Hou P; Liu K; Niu X; Wei B; Mao F; Xu Z
    Chem Biol Interact; 2018 Oct; 294():40-47. PubMed ID: 30125550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periplocin from Cortex periplocae inhibits cell growth and down-regulates survivin and c-myc expression in colon cancer in vitro and in vivo via beta-catenin/TCF signaling.
    Zhao L; Shan B; Du Y; Wang M; Liu L; Ren FZ
    Oncol Rep; 2010 Aug; 24(2):375-83. PubMed ID: 20596624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma.
    Fan X; Ma X; Cui L; Dang S; Qu J; Zhang J; Wang X; Mao Z
    Oncotarget; 2016 Dec; 7(49):80404-80414. PubMed ID: 27829235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
    Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
    Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation.
    Feng Y; Bommer GT; Zhai Y; Akyol A; Hinoi T; Winer I; Lin HV; Cadigan KM; Cho KR; Fearon ER
    Cancer Res; 2007 Jan; 67(2):482-91. PubMed ID: 17234755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-suppressive miR-145 co-repressed by TCF4-β-catenin and PRC2 complexes forms double-negative regulation loops with its negative regulators in colorectal cancer.
    Wang W; Xiao X; Chen X; Huo Y; Xi WJ; Lin ZF; Zhang D; Li YF; Yang F; Wen WH; Yang AG; Wang T
    Int J Cancer; 2018 Jan; 142(2):308-321. PubMed ID: 28921929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Positive Feed-Forward Loop between LncRNA-CYTOR and Wnt/β-Catenin Signaling Promotes Metastasis of Colon Cancer.
    Yue B; Liu C; Sun H; Liu M; Song C; Cui R; Qiu S; Zhong M
    Mol Ther; 2018 May; 26(5):1287-1298. PubMed ID: 29606502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Catenin/TCF4 Complex-Mediated Induction of the
    Aono S; Hatanaka A; Hatanaka A; Gao Y; Hippo Y; Taketo MM; Waku T; Kobayashi A
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31288376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
    Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
    BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.